People: Acura Pharmaceuticals Inc (ACUR.O)
2.37USD
24 May 2013
$0.01 (+0.42%)
$2.36
$2.42
$2.42
$2.30
137,922
738,022
$4.50
$1.06
Clemens, Peter
Brief Biography
Mr. Peter A. Clemens is Chief Financial Officer, Senior Vice President, Secretary of Acura Pharmaceuticals, Inc., since April 2004. Mr. Clemens was Vice President, Chief Financial Officer and Secretary from February 1998 to March 2004 and a member of the Board of Directors from June, 1998 to August, 2004. Mr. Clemens is a Certified Public Accountant and earned a Bachelor of Business Administration degree from the University of Notre Dame and a Masters of Business Administration from Indiana University.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 219,000 | -- | 121,863 | 340,863 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | 718,750 | 12,656.00 |
| Unexercisable | 281,250 | 37,969.00 |
| Excercised | 9,375 | 20,531.00 |
| Name | Fiscal Year Total |
|---|---|
Robert Jones |
602,353 |
Peter Clemens |
340,863 |
Robert Seiser |
267,490 |
J. Bradley Rivet |
352,988 |
Albert Brzeczko |
452,608 |
James Emigh |
267,490 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
